# Dianthus Therapeutics, Inc.: Form SC 13D/A, filed May 5, 2022

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: SC 13D/A
- Filed: 2022-05-05
- Accepted by EDGAR: May 5, 2022, 16:01 ET
- Period: not reported
- Accession: 0001387131-22-005741
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000138713122005741/magenta-sc13da_041322.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000138713122005741/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000138713122005741/magenta-sc13da_041322.htm

Filed May 5, 2022.
Source: SEC EDGAR, the filing index for accession 0001387131-22-005741. Last ingested by Listed: Nov 4, 2026, 16:45 ET. No prices; not investment advice.